Gene · 10112
Papers1,613
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,613
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Prognostic modeling and immune infiltration analysis in hepatocellular carcinoma using glutathione metabolism-associated genes. | Eur J Med Res | 2025 | 41257940 | PubTator, text mining | PubMed |
| Plasma exosomal lncRNA-related signatures define molecular subtypes and predict survival and treatment response in hepatocellular carcinoma. | Front Immunol | 2025 | 41169384 | PubTator, text mining | PubMed |
| Programmed cell death-related genes define distinct molecular subtypes and risk profiles in hepatocellular carcinoma. | Sci Rep | 2025 | 41131074 | PubTator, text mining | PubMed |
| Comparative bioinformatics analysis of the Wnt pathway in breast cancer: Selection of novel biomarker panels associated with ER status. | Open Life Sci | 2025 | 41079598 | PubTator, text mining | PubMed |
| CKS2 is overexpressed in high-grade and recurrent meningiomas and functions as an oncogene via the CKS2/miR-26a/miR-101 axis. | Comput Biol Med | 2025 | 41061391 | PubTator, text mining | PubMed |
| In-silico identification of host-key-genes associated with dengue-virus-infections highlighting their pathogenetic mechanisms and therapeutic agents. | PLoS One | 2025 | 41056367 | PubTator, text mining | PubMed |
Tumor microenvironment delineates differential responders to trastuzumab emtansine in HER2-positive metastatic breast cancer patients previously treated with pyrotinib: an exploratory biomarker analysis of a phase II study (NJMU-BC02). | Signal Transduct Target Ther | 2025 | 41016944 | PubTator, text mining | PubMed |
| Kinesin superfamily proteins in cancer: unveiling their role in chemotherapy. | Int Immunopharmacol | 2025 | 41016201 | PubTator, text mining | PubMed |
| Identification of prognostic biomarkers for hepatocellular carcinoma based on the m6A RNA modification. | Int J Immunopathol Pharmacol | 2025 | 41013996 | PubTator, text mining | PubMed |
| Metabolic heterogeneity and survival outcomes in papillary renal cell carcinoma: insights from multi-datasets and machine learning analyses. | Hereditas | 2025 | 41013841 | PubTator, text mining | PubMed |
| Development and Validation of a Centrosome Amplification-Related Prognostic Model in Pancreatic Cancer: Multi-Omics Guided Risk Stratification and Tumor Microenvironment. | Cancers (Basel) | 2025 | 41008826 | PubTator, text mining | PubMed |
| Ferroptosis-Linked Six-Gene Panel Enables Machine Learning-Assisted Diagnosis and Therapeutic Guidance in Lung Adenocarcinoma. | Biology (Basel) | 2025 | 41007424 | PubTator, text mining | PubMed |
| Does microtubule motor-mediated centrosomal dyshomeostasis confer chemoresistance in breast cancer? | J Mammary Gland Biol Neoplasia | 2025 | 41003863 | PubTator, text mining | PubMed |
| Role of intratumoral heterogeneity in metastatic progression and drug resistance. | Discov Oncol | 2025 | 40965714 | PubTator, text mining | PubMed |
| Promising Cancer Vaccine for Glioblastoma Therapy: A Focus on mRNA Vaccine. | Cancer Med | 2025 | 40948290 | PubTator, text mining | PubMed |
| Recent Advances in the Application of Cucurbitacin B as an Anticancer Agent. | Int J Mol Sci | 2025 | 40869325 | PubTator, text mining | PubMed |
| Identification of biomarkers and potential therapeutic targets of breast cancer using bioinformatics analysis. | Medicine (Baltimore) | 2025 | 40826700 | PubTator, text mining | PubMed |
| Identification of key ferroptosis-related genes and therapeutic target in nasopharyngeal carcinoma. | Front Genet | 2025 | 40822284 | PubTator, text mining | PubMed |
| From laboratory to clinic: opportunities and challenges of functional food active ingredients in cancer therapy. | Front Nutr | 2025 | 40808836 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing uncovers dynamic roadmap during chicken spermatogenesis. | BMC Genomics | 2025 | 40804371 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10112/papers?page=4